Although no significant differences were observed between patient groups for the three signatures, levels of GPC1+ve EVs were actually decreased in metastatic pancreatic cancer patients (6,062 EVs/microliter) compared to resected cancer (11,958 EVs/microliter) and BPD (25,911 EVs/microliter) groups. The gene discussed is GPC1; the disease is cancer.